Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Embolism × 1 year × Clear all

Status

Active not recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Carcinoma, Non-Small-Cell Lung 851 Neoplasms 564 Breast Neoplasms 531 Colorectal Neoplasms 403 Neoplasm Metastasis 350 Ovarian Neoplasms 294 Melanoma 294 Prostatic Neoplasms 281 Multiple Myeloma 276 Lung Neoplasms 266 Recurrence 263 Squamous Cell Carcinoma of Head and Neck 232 Leukemia, Myeloid, Acute 218 Pancreatic Neoplasms 210 Stomach Neoplasms 203 Endometrial Neoplasms 175 Triple Negative Breast Neoplasms 168 Carcinoma, Renal Cell 167 Lymphoma, Non-Hodgkin 160 Carcinoma, Hepatocellular 157 Small Cell Lung Carcinoma 145 Leukemia, Lymphocytic, Chronic, B-Cell 143 Advanced Solid Tumors 136 Lymphoma, Follicular 133 Lymphoma, Large B-Cell, Diffuse 131 Urinary Bladder Neoplasms 128 Glioblastoma 125 Uterine Cervical Neoplasms 124 Lymphoma 123 Head and Neck Neoplasms 123

Interventions

edoxaban 1 apixaban 1 Rivaroxaban 1 Heparin, Low-Molecular-Weight 1 Dabigatran 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04618913 2026-03-12

VICTORIE

Pfizer

Active not recruiting

Classical hematology

Embolism, Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡